Results 211 to 220 of about 17,995 (248)
Exploring Ayurveda's Potential in Parkinson's Disease: A Comprehensive Narrative. [PDF]
CureusChikkanna U +7 more
europepmc +1 more source
Factors associated with sleep disorders in elderly patients with Parkinson's disease and cognitive impairment and the nomogram model development. [PDF]
Front Aging NeurosciZhang Y, Sun L, Chi H.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Neuropharmacology, 2018
Background d-Decarboxylase inhibitors, such as carbidopa or benserazide, have been used as adjunct therapy in Parkinson disease shortly after levodopa synthesis in the 1960s. These compounds increase intracerebral drug concentration and decrease adverse effects by blocking peripheral conversion
Mariana Aurora, Cansino-Torres +3 more
openaire +2 more sources
Background d-Decarboxylase inhibitors, such as carbidopa or benserazide, have been used as adjunct therapy in Parkinson disease shortly after levodopa synthesis in the 1960s. These compounds increase intracerebral drug concentration and decrease adverse effects by blocking peripheral conversion
Mariana Aurora, Cansino-Torres +3 more
openaire +2 more sources
The American Journal of Emergency Medicine, 1991
A 57-year-old woman ingested 15 to 17 tablets of carbidopa-levodopa 10/100 tablets (carbidopa 150 mg and levodopa 1,500 mg) along with ibuprofen, carisoprodol, hydrocodone, and acetaminophen. The patient developed choreiform movements that persisted despite obtundation and attempts to extinguish them with naloxone, morphine, and diazepam.
openaire +2 more sources
A 57-year-old woman ingested 15 to 17 tablets of carbidopa-levodopa 10/100 tablets (carbidopa 150 mg and levodopa 1,500 mg) along with ibuprofen, carisoprodol, hydrocodone, and acetaminophen. The patient developed choreiform movements that persisted despite obtundation and attempts to extinguish them with naloxone, morphine, and diazepam.
openaire +2 more sources